ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

“Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases

September 18, 1981

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005

DCCP Board Approves Concept Of NMR Interintuitional Clinical Research

January 27, 1984

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974